Skip to main content

Methotrexate in the treatment of idiopathic granulomatous mastitis

8Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Objective. Idiopathic granulomatous mastitis (IGM) is a disfiguring inflammatory breast disease without effective treatment. We report the largest IGM cohort treated with methotrexate (MTX) monotherapy. Methods. Chart review was performed on patients evaluated by the Stanford Immunology and Rheumatology Clinic, with histopathologically established IGM treated with MTX, and at least 1 followup appointment. Results. Nineteen female patients with a mean age of 33.5 years were identified. Most failed treatment with antibiotics, prednisone, and surgical intervention. By 15 months of treatment with MTX, 94% had disease improvement and 75% achieved disease remission. Conclusion. MTX monotherapy is an effective treatment for IGM.

Cite

CITATION STYLE

APA

Postolova, A., Troxell, M. L., Wapnir, I. L., & Genovese, M. C. (2020). Methotrexate in the treatment of idiopathic granulomatous mastitis. Journal of Rheumatology, 47(6), 924–927. https://doi.org/10.3899/jrheum.181205

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free